Monthly Archives: May 2009

Boogie Board Co-Founder Rides Wave Discusses Success at Startup Junkie

Monday’s Startup Junkie Underground featured Patti Serrano telling the story of building the Boogie Board into a national phenomenon and her role in that process. The story began when Serrano reconnected with an old friend, Tom Morey, who had come up with the idea for the Boogie Board, now known as a body board. [...]

iggli Partners with Artists, Venues and Promoters in Socializing Ticket Purchasing

In the business of ticket sellers, Tom Higley points to one phenomenon standing between the artists and venues that put on a show and the uncollected billions in unsold tickets and seats: the problem of the bad friend. In Tom’s description, it’s this bad friend (“Bobby”) who has historically given ticket purchasers pause when buying [...]

New Boulder Company Clovis Oncology Raises $145M

Clovis Oncology, a new company focused on acquiring, developing and commercializing innovative anti-cancer agents worldwide, announced it has raised $145M in initial funding. Participants in the funding round include: Domain Associates, New Enterprise Associates (NEA), Versant Ventures, Aberdare Ventures, Abingworth, Frazier Healthcare Ventures, ProQuest Investments and the Company’s management team. Likely essential to this [...]

May New Tech Meetup – Denver Edition

The Boulder Denver New Tech Meetup (Denver edition) held its third meeting to a substantial crowd on a balmy spring evening. With a crowd of over 50% first time attendees, BDNT continues to demonstrate its ability to refresh its base while providing longstanding members new features, formats, and first looks at new firms. Last night [...]

Array BioPharma Receives Additional $40M Funding Commitment

Array BioPharma Inc. announced yesterday that it had received an additional $40M funding commitment from Deerfield Management of New York. This funding comes in addition to the $80M provided by Deerfield, a leading healthcare investment firm and one of Array’s largest investors, in 2008. According to Array CEO, Robert E. Conway: “These additional [...]

May Green Tech Meetup Recap

After a month off, May’s Green Tech Meetup took place in the more spacious confines of the Wittemyer courtroom in the Wolf Law building at CU Boulder. The evening afforded all those in attendance a comfortable seat along with presentations from four diverse companies.

MicroPhage Rapid Bacterial Test Shown Effective in Soft Tissue Samples

MicroPhage, Inc. recently presented data showing its test to be highly accurate for rapid identification of serious staph bacterial infections from skin and soft tissue samples. From the group of 33 samples tested, the MicroPhage rapid assay correctly identified seven of the eight samples later shown to be Staphylococcus aureus by traditional microbiology methods. [...]

A Conversation with Crash Corp’s Matt Galligan

Matt Galligan, the co-founder of Socialthing and recent big-picture-guy for AOL, doesn’t mind strapping on a healthy amount of calculated risk. Whether it’s buying a motorcycle or experimenting with video blogging to a (hilariously) unforgiving audience of friends, the twenty-four-year old is hardly a wallflower. So it comes as little surprise that Galligan – less [...]

May Innovation After Hours Features VanDyne SuperTurbo

May’s Innovation After Hours featured a brief update from Judy Dorsey followed by a presentation from Ed VanDyne of VanDyne SuperTurbo. Dorsey described some of the activities of the Northern Colorado Clean Energy Cluster which she described as both a “public private partnership” and a “project oriented” organization. Most visible of the organization’s [...]

BioDesix VeriStrat Test Shows Promise in Identifying Treatment Success in Head and Neck Cancer

BioDesix, Inc released additional data related to the use of its VeriStrat test in head and neck cancer. The data demonstrates that VeriStrat showed predictive value in indentifying patients who were likely to benefit from treatment with epidermal growth factor inhibitors (EGFRIs). An overall survival benefit was observed in patients identified by the [...]